Pages that link to "Q33724231"

The following pages link to The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis (Q33724231):

Displaying 47 items.

• Targeting MicroRNA Function in Respiratory Diseases: Mini-Review (Q26766476) (← links)
• Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension (Q26801345) (← links)
• MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics (Q28068338) (← links)
• The code of non-coding RNAs in lung fibrosis (Q28386827) (← links)
• MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix (Q34356445) (← links)
• RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease (Q36134941) (← links)
• MicroRNAs as potential targets for progressive pulmonary fibrosis (Q36249425) (← links)
• miR-27b inhibits fibroblast activation via targeting TGFβ signaling pathway (Q36251724) (← links)
• MicroRNA-27a-3p Is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation (Q37088324) (← links)
• The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy (Q37427986) (← links)
• MicroRNA Mediating Networks in Granulosa Cells Associated with Ovarian Follicular Development (Q37681525) (← links)
• Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions (Q38258015) (← links)
• Epigenetic targets for novel therapies of lung diseases (Q38275276) (← links)
• MicroRNA regulatory networks in idiopathic pulmonary fibrosis. (Q38306947) (← links)
• A key role of microRNA-26a in the scar formation after glaucoma filtration surgery (Q38689911) (← links)
• miR-19a, -19b, and -26b Mediate CTGF Expression and Pulmonary Fibroblast Differentiation (Q38794416) (← links)
• Detecting the Molecular System Signatures of Idiopathic Pulmonary Fibrosis through Integrated Genomic Analysis (Q38796898) (← links)
• TGF-β: the master regulator of fibrosis (Q38816052) (← links)
• TGF-β Signaling from Receptors to Smads (Q38906099) (← links)
• MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis. (Q38917573) (← links)
• miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II. (Q38993906) (← links)
• Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases. (Q39096514) (← links)
• Novel Anti-fibrotic Therapies (Q39377055) (← links)
• MicroRNAs in mucosal inflammation. (Q39446959) (← links)
• The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis (Q40689849) (← links)
• MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy (Q40848218) (← links)
• Microrna-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor (CTGF) and cyclin D1 (CCND1). (Q42317554) (← links)
• MicroRNA-26b functions as a proapoptotic factor in porcine follicular Granulosa cells by targeting Sma-and Mad-related protein 4. (Q44784192) (← links)
• MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1. (Q47104906) (← links)
• A novel lnc-PCF promotes the proliferation of TGF-β1-activated epithelial cells by targeting miR-344a-5p to regulate map3k11 in pulmonary fibrosis (Q47149080) (← links)
• Role of MicroRNAs in TGF-β Signaling Pathway-Mediated Pulmonary Fibrosis (Q47382571) (← links)
• LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d (Q49788031) (← links)
• MEKK1, JNK, and SMAD3 mediate CXCL12-stimulated connective tissue growth factor expression in human lung fibroblasts (Q51418425) (← links)
• Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway. (Q52593627) (← links)
• miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF. (Q52667269) (← links)
• MicroRNA-26a and -26b inhibit lens fibrosis and cataract by negatively regulating Jagged-1/Notch signaling pathway. (Q52859357) (← links)
• Lung fibroblasts express a miR-19a-19b-20a sub-cluster to suppress TGF-β-associated fibroblast activation in murine pulmonary fibrosis (Q58571239) (← links)
• miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease (Q58604344) (← links)
• Molecular pathogenesis involved in human idiopathic pulmonary fibrosis based on an integrated microRNA‑mRNA interaction network (Q58762351) (← links)
• MicroRNA dysregulation in lung injury: the role of the miR-26a/EphA2 axis in regulation of endothelial permeability (Q60111042) (← links)
• DROSHA-Dependent miRNA and AIM2 Inflammasome Activation in Idiopathic Pulmonary Fibrosis (Q89977176) (← links)
• lncRNA PFAR Promotes Lung Fibroblast Activation and Fibrosis by Targeting miR-138 to Regulate the YAP1-Twist Axis (Q90347193) (← links)
• Molecular determinants of mesenchymal cell activation in fibroproliferative diseases (Q90348644) (← links)
• Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease (Q90590346) (← links)
• YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF (Q91050144) (← links)
• LncRNA PFAR contributes to fibrogenesis in lung fibroblasts through competitively binding to miR-15a (Q91620798) (← links)
• Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis (Q92656928) (← links)